MEPHYTON Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Mephyton, and what generic alternatives are available?
Mephyton is a drug marketed by Bausch and is included in one NDA.
The generic ingredient in MEPHYTON is phytonadione. There are ten drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the phytonadione profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Mephyton
A generic version of MEPHYTON was approved as phytonadione by AMNEAL PHARMS CO on May 11th, 2018.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MEPHYTON?
- What are the global sales for MEPHYTON?
- What is Average Wholesale Price for MEPHYTON?
Summary for MEPHYTON
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 103 |
| Clinical Trials: | 1 |
| Patent Applications: | 3,627 |
| Drug Prices: | Drug price information for MEPHYTON |
| What excipients (inactive ingredients) are in MEPHYTON? | MEPHYTON excipients list |
| DailyMed Link: | MEPHYTON at DailyMed |
Recent Clinical Trials for MEPHYTON
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of North Carolina, Chapel Hill | N/A |
US Patents and Regulatory Information for MEPHYTON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch | MEPHYTON | phytonadione | TABLET;ORAL | 010104-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
